StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 7, 2026, 06:13 AM

22nd Century Group Q1 Net Revenue $4.1M, Net Loss $(3.0)M

AI Summary

22nd Century Group reported first-quarter 2026 net revenues of $4.1 million, a 31.1% decrease year-over-year, but a slight increase from Q4 2025. The net loss from continuing operations improved to $(3.0) million compared to $(3.3) million in Q1 2025. The company continues to expand VLN® commercial distribution, targeting over 5,000 retail outlets by year-end 2026, and is advancing its PMTA portfolio and licensing strategy for new low-nicotine tobacco products.

Key Highlights

  • Net revenues were $4.1 million, down 31.1% year-over-year from $5.956 million.
  • Net loss from continuing operations improved to $(3.0) million from $(3.3) million year-over-year.
  • Adjusted EBITDA loss increased to $(2.6) million from $(2.3) million year-over-year.
  • Cash and cash equivalents stood at $9.5 million at the end of the quarter.
  • VLN® products are available in over 2,000 stores across 20 states.
  • Company targets over 5,000 retail outlets for VLN® by the end of 2026.
  • Zero long-term debt was reported at the end of the quarter.